Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Lung function

Lung infection by Pseudomonas aeruginosa in children with cystic fibrosis: risk factors and impact on lung function

  • Read more about Lung infection by Pseudomonas aeruginosa in children with cystic fibrosis: risk factors and impact on lung function

Quality of life and health outcomes in children with CF aged 5 years

  • Read more about Quality of life and health outcomes in children with CF aged 5 years

Comparing oral glucose tolerance test and continuous glucose monitoring

  • Read more about Comparing oral glucose tolerance test and continuous glucose monitoring

Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis

  • Read more about Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis

ACT with CF: A telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis

  • Read more about ACT with CF: A telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis

Prospective longitudinal association between repeated multiple breath washout measurements and computed tomography scores in children with cystic fibrosis

  • Read more about Prospective longitudinal association between repeated multiple breath washout measurements and computed tomography scores in children with cystic fibrosis

Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial

  • Read more about Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial

Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development

  • Read more about Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development

Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease

  • Read more about Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease

Influenza B outbreak at an adult cystic fibrosis centre - clinical impact and factors influencing spread

  • Read more about Influenza B outbreak at an adult cystic fibrosis centre - clinical impact and factors influencing spread
  • first
  • previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)